Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells

Vaccine-specific CD4(+) T cell, CD8(+) T cell, binding antibody, and neutralizing antibody responses to the 25-μg Moderna messenger RNA (mRNA)–1273 vaccine were examined over the course of 7 months after immunization, including in multiple age groups, with a particular interest in assessing whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateus, Jose, Dan, Jennifer M., Zhang, Zeli, Rydyznski Moderbacher, Carolyn, Lammers, Marshall, Goodwin, Benjamin, Sette, Alessandro, Crotty, Shane, Weiskopf, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542617/
https://www.ncbi.nlm.nih.gov/pubmed/34519540
http://dx.doi.org/10.1126/science.abj9853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542617/
https://www.ncbi.nlm.nih.gov/pubmed/34519540
http://dx.doi.org/10.1126/science.abj9853

Ejemplares similares